ArticleTherapeutic advances in medical oncology2022

Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.

Yijia Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.